QXO Inc header image

QXO Inc

QXO

Equity

ISIN null / Valor 135786409

NASDAQ (2026-01-21)
USD 23.47-0.21%

QXO Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

QXO Inc. is a technology solutions provider that primarily serves clients in the manufacturing, distribution, and service sectors. The company offers a range of services including consulting, professional services, specialized programming, training, and technical support. As a value-added reseller, QXO supplies business application software solutions for various functions such as accounting, financial reporting, enterprise resource planning, warehouse management, customer relationship management, and business intelligence. In addition to reselling, QXO develops and publishes its own proprietary software. The company is strategically positioning itself to become a leader in the building products distribution industry, which is valued at $800 billion. QXO aims to achieve significant revenue growth through both acquisitions and organic expansion, leveraging the industry's increasing adoption of technology, particularly in AI and B2B e-commerce. The company sees opportunities in enhancing customer experience, sales force effectiveness, and margin expansion through technological advancements like price optimization, demand forecasting, and warehouse automation. The building products distribution sector is notably fragmented, with thousands of distributors across North America and Europe, presenting a substantial market opportunity for QXO's tech-driven approach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (03.01.2026):

QXO Inc (QXO, Inc.) reported third quarter 2025 results: net sales of $2.728 billion, a GAAP net loss of $139.4 million (basic and diluted loss per share $0.24) and positive non‑GAAP performance including Adjusted Net Income of $166.2 million and Adjusted Diluted EPS of $0.14 for the three months ended September 30, 2025. Adjusted EBITDA was $301.9 million (11.1% margin). Management emphasized progress integrating Beacon and reiterated long‑term growth targets.

Revenue and margins

Net sales of $2.728 billion in Q3 2025; gross profit $635.8 million (GAAP gross margin 23.3%) and Adjusted Gross Margin 25.2% after inventory fair‑value adjustments.

GAAP vs. non‑GAAP results

GAAP: net loss $(139.4)M, loss per share $(0.24). Non‑GAAP: Adjusted Net Income $166.2M, Adjusted Diluted EPS $0.14, Adjusted EBITDA $301.9M (11.1% of sales).

Balance sheet and liquidity

Total assets $16.6429 billion; cash and cash equivalents ~$2.307 billion; inventories ~$1.664 billion; goodwill ~$5.071 billion; long‑term debt, net ~$3.053 billion. Total liabilities ~$6.821 billion.

Cash flow and financing activity

Nine‑month investing cash outflow included $10.5565 billion for acquisitions; operating cash provided $74.8 million year‑to‑date; financing activities provided ~$7.769 billion (including ~$4.256 billion net equity proceeds and $558.1 million from mandatory convertible preferred issuance).

Acquisition and non‑recurring items

Results reflect the Beacon acquisition: inventory fair‑value adjustment of $51.4M this quarter (expected to be fully recognized in 2025), amortization of $117.8M, and other one‑time transaction, transformation and restructuring costs included in reconciliations to non‑GAAP measures.

Shares and EPS calculations

Reported basic/diluted weighted‑average common shares outstanding: 715.3 million; adjusted diluted weighted‑average shares used for Adjusted Diluted EPS: 875.3 million. Adjusted results subtract preferred dividends and allocations to participating securities when calculating adjusted amounts attributable to common holders.

Management commentary and outlook

CEO Brad Jacobs highlighted optimization of Beacon, a goal to grow legacy Beacon EBITDA to >$2 billion and a corporate target of $50 billion in annual revenue within a decade; forward‑looking statements are subject to risks described in the release.

Summarized from source with an LLMView Source

Key figures

71.6%1Y
-12.9%3Y
-33.5%5Y

Performance

55.7%1Y
151%3Y
129%5Y

Volatility

Market cap

15828 M

Market cap (USD)

Daily traded volume (Shares)

9,949,922

Daily traded volume (Shares)

1 day high/low

15.59 / 14.98

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Mobileye Global Inc
Mobileye Global Inc Mobileye Global Inc Valor: 122239832
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 10.88
Arrow Electronics Inc
Arrow Electronics Inc Arrow Electronics Inc Valor: 908955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.29%USD 118.23
MasTec Inc
MasTec Inc MasTec Inc Valor: 209076
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 243.80
nVent Electric PLC
nVent Electric PLC nVent Electric PLC Valor: 41275889
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.51%USD 112.66
UiPath Inc
UiPath Inc UiPath Inc Valor: 110831715
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 14.20
GameStop Corp New
GameStop Corp New GameStop Corp New Valor: 2274310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.80%USD 21.69
Avidity Biosciences Inc
Avidity Biosciences Inc Avidity Biosciences Inc Valor: 54991635
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 72.65
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc Cartesian Therapeutics Inc Valor: 134256445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.67%USD 7.64
AdCapital AG
AdCapital AG AdCapital AG Valor: 324972
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.26
Joby Aviation Incorporation
Joby Aviation Incorporation Joby Aviation Incorporation Valor: 113133115
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.85%USD 14.30